UTHR•benzinga•
B of A Securities Upgrades United Therapeutics to Neutral, Maintains Price Target to $314
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 21, 2025 by benzinga